St.

Search Options

HomeContact Us Newsletter Sign-up
Our Services Find an Event Find a Physician Health Resources Careers About Us

Press Releases
About Us
Careers
Our Services
Press Releases
Tenet Healthcare Corp.
For Physicians

   Saint Louis University Cancer Center: Personalized, Advanced Treatment
Saint Louis University, Tenet Healthcare Collaborate

ST. LOUIS -The Saint Louis University Cancer Center, a renovated, advanced facility in midtown St. Louis, combines some of the latest advances in research, prevention and education with compassionate, personalized care.

The SLU Cancer Center is operated and funded by Saint Louis University and Tenet Healthcare. It occupies 50,000 square feet at 3655 Vista Ave., in Saint Louis University Hospital's West Pavilion, which had been Bethesda General Hospital. 

The SLU Cancer Center uses some of the latest screening and diagnostic tools from across the Saint Louis University Health Sciences Center to detect cancer – including an advanced Breast Imaging Center, an advanced endoscopy suite, computed tomography scans, positron emission tomography and MRI.

Healthcare professionals from Saint Louis University collaborate to create personalized care plans, including investigational treatments that are unavailable in many clinical practices. No two treatment approaches are the same because every patient's condition is different.

The center's Community Cancer Resource Center extends its personalized approach to education still further. Staffed by oncology professionals, the center offers multimedia information services and outreach seminars to educate patients, families and members of the community about cancer detection, prevention and treatment.

For more information about the SLU Cancer Center or to schedule an appointment, call 314-268-5880.

email this page to a friend
Related Information
Health Resources
PR Newswire via NewsEdge Corporation : SEATTLE, May 5 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN) today announced that the D9901 Phase 3 clinical trial results of Provenge(R), the Company's investigational immunotherapy for the treatment of prostate cancer in men with asymptomatic, metastatic androgen-independent (hormone refractory) prostate cancer, will be presented during an oral presentation at the 2005 American Society of Clinical Oncology (ASCO) Annual Meeting taking place in Orlando, Fla. May 13 - 17. Details are as follows:
Find Vaginal Cancer Services
Find Male Breast Cancer Services
More... >
Hospital Affiliated Physicians
Oncology
Hospital Information & Services
Saint Louis University Cancer Center Fact Sheet
Saint Louis University Cancer Center: Personalized, Advanced Treatment
Medical & Community Services
Cancer Services
Spiritual Care for Cancer Patients
Cancer Information Center
More... >